2 Revolutionary Biotech Stocks to Buy Right Now
Here’s a simple argument for why long-term investors should consider buying shares of biotech companies. Since its inception in 2006, the SPDR S&P Biotech Index — an industry benchmark — has crushed the S&P 500, as the graph below shows.
^SPX data by YCharts
This graph doesn’t show us the specific biotech stocks that performed well throughout this period, and we can’t assume the trend will continue indefinitely; after all, the market is forward-looking. Still, there are excellent bio…